Cargando…

PB1808: EPIGENETIC INHIBITOR SCREEN TO IDENTIFY THERAPEUTIC CANDIDATES FOR MNX1-OVEREXPRESSING AML

Detalles Bibliográficos
Autores principales: Kelekci, Simge, Riedel, Anna, Weichenhan, Dieter, Goyal, Ashish, Kelly, Katherine, Baehr, Marion, Michels, Birgitta, Koerner, Cindy, Orzella, Irene, Dunford, James, Lutsik, Pavlo, Wiemann, Stefan, Oppermann, Udo, Plass, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429982/
http://dx.doi.org/10.1097/01.HS9.0000974080.68856.1e
_version_ 1785090847708020736
author Kelekci, Simge
Riedel, Anna
Weichenhan, Dieter
Goyal, Ashish
Kelly, Katherine
Baehr, Marion
Michels, Birgitta
Koerner, Cindy
Orzella, Irene
Dunford, James
Lutsik, Pavlo
Wiemann, Stefan
Oppermann, Udo
Plass, Christoph
author_facet Kelekci, Simge
Riedel, Anna
Weichenhan, Dieter
Goyal, Ashish
Kelly, Katherine
Baehr, Marion
Michels, Birgitta
Koerner, Cindy
Orzella, Irene
Dunford, James
Lutsik, Pavlo
Wiemann, Stefan
Oppermann, Udo
Plass, Christoph
author_sort Kelekci, Simge
collection PubMed
description
format Online
Article
Text
id pubmed-10429982
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104299822023-08-17 PB1808: EPIGENETIC INHIBITOR SCREEN TO IDENTIFY THERAPEUTIC CANDIDATES FOR MNX1-OVEREXPRESSING AML Kelekci, Simge Riedel, Anna Weichenhan, Dieter Goyal, Ashish Kelly, Katherine Baehr, Marion Michels, Birgitta Koerner, Cindy Orzella, Irene Dunford, James Lutsik, Pavlo Wiemann, Stefan Oppermann, Udo Plass, Christoph Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429982/ http://dx.doi.org/10.1097/01.HS9.0000974080.68856.1e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Kelekci, Simge
Riedel, Anna
Weichenhan, Dieter
Goyal, Ashish
Kelly, Katherine
Baehr, Marion
Michels, Birgitta
Koerner, Cindy
Orzella, Irene
Dunford, James
Lutsik, Pavlo
Wiemann, Stefan
Oppermann, Udo
Plass, Christoph
PB1808: EPIGENETIC INHIBITOR SCREEN TO IDENTIFY THERAPEUTIC CANDIDATES FOR MNX1-OVEREXPRESSING AML
title PB1808: EPIGENETIC INHIBITOR SCREEN TO IDENTIFY THERAPEUTIC CANDIDATES FOR MNX1-OVEREXPRESSING AML
title_full PB1808: EPIGENETIC INHIBITOR SCREEN TO IDENTIFY THERAPEUTIC CANDIDATES FOR MNX1-OVEREXPRESSING AML
title_fullStr PB1808: EPIGENETIC INHIBITOR SCREEN TO IDENTIFY THERAPEUTIC CANDIDATES FOR MNX1-OVEREXPRESSING AML
title_full_unstemmed PB1808: EPIGENETIC INHIBITOR SCREEN TO IDENTIFY THERAPEUTIC CANDIDATES FOR MNX1-OVEREXPRESSING AML
title_short PB1808: EPIGENETIC INHIBITOR SCREEN TO IDENTIFY THERAPEUTIC CANDIDATES FOR MNX1-OVEREXPRESSING AML
title_sort pb1808: epigenetic inhibitor screen to identify therapeutic candidates for mnx1-overexpressing aml
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429982/
http://dx.doi.org/10.1097/01.HS9.0000974080.68856.1e
work_keys_str_mv AT kelekcisimge pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml
AT riedelanna pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml
AT weichenhandieter pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml
AT goyalashish pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml
AT kellykatherine pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml
AT baehrmarion pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml
AT michelsbirgitta pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml
AT koernercindy pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml
AT orzellairene pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml
AT dunfordjames pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml
AT lutsikpavlo pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml
AT wiemannstefan pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml
AT oppermannudo pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml
AT plasschristoph pb1808epigeneticinhibitorscreentoidentifytherapeuticcandidatesformnx1overexpressingaml